# Biomarker Guided Treatment in Gynaecological Cancer

> **NCT02543710** · PHASE4 · RECRUITING · sponsor: **Haukeland University Hospital** · enrollment: 1300 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **PROCEDURE:** Biomarker (ER/PR) guided lymphadenectomy
- **DRUG:** Biomarker guided weekly taxane treatment in endometrial/ ovarian cancer

## Key facts

- **NCT ID:** NCT02543710
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-10
- **Primary completion:** 2020-12
- **Final completion:** 2033-12
- **Target enrollment:** 1300 (ESTIMATED)
- **Last updated:** 2017-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02543710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02543710, "Biomarker Guided Treatment in Gynaecological Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02543710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*